Proquad vials
Ended Awarded
- Contract number
- SPE2DB25FR9UY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,750
Award facts
- Contract value 100% obligated
- $6,749.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,749.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on September 15, 2025, with completion scheduled for October 6, 2025. This non-competitive delivery order represents a small-value pharmaceutical transaction executed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, making this order consistent with the federal government's medical supply procurement needs for military and veteran healthcare systems.
This delivery order is a child contract under AmerisourceBergen's prime indefinite delivery vehicle with the Defense Logistics Agency, valued at $999.99 million through December 2026, which serves as a comprehensive pharmaceutical support vehicle for global military healthcare programs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—where the vaccines will be delivered—is a major pharmaceutical distributor that regularly fulfills federal medical procurement requirements through competitive and non-set-aside contracts. The company's extensive federal contract portfolio demonstrates its capacity to deliver brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB25FR9UY?
SPE2DB25FR9UY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FR9UY worth?
The government has obligated $6,750 on SPE2DB25FR9UY.
Is contract SPE2DB25FR9UY an order under another contract?
Yes. SPE2DB25FR9UY is a delivery order under SPE2DB22D2103, an indefinite delivery contract.
Was contract SPE2DB25FR9UY competed?
The extent of competition for SPE2DB25FR9UY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award